We observed increases in both Ppara and Pparg mRNA expression in rats regardless of treatment with insulin and/or hCG, and this suggests that the induction of varying degrees of hepatic steatosis by the different treatments depends on the balance between PPARα and PPARβ activity. Here, PPARD is linked to fatty liver disease.